Projekt

A phase I / II, open-label, multiple-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VT-464 in chemotherapy-naïve patients with castration-refractory prostate cancer. Sponsor:

Automatisch geschlossen · 2011 bis 2013

Gillessen Sommer Silke, Rothermundt Christian, Hess Dagmar